Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 14;12(7):e0178231.
doi: 10.1371/journal.pone.0178231. eCollection 2017.

Charged amino acid variability related to N-glyco -sylation and epitopes in A/H3N2 influenza: Hem -agglutinin and neuraminidase

Affiliations

Charged amino acid variability related to N-glyco -sylation and epitopes in A/H3N2 influenza: Hem -agglutinin and neuraminidase

Zhong-Zhou Huang et al. PLoS One. .

Abstract

Background: The A/H3N2 influenza viruses circulated in humans have been shown to undergo antigenic drift, a process in which amino acid mutations result from nucleotide substitutions. There are few reports regarding the charged amino acid mutations. The purpose of this paper is to explore the relations between charged amino acids, N-glycosylation and epitopes in hemagglutinin (HA) and neuraminidase (NA).

Methods: A total of 700 HA genes (691 NA genes) of A/H3N2 viruses were chronologically analyzed for the mutational variants in amino acid features, N-glycosylation sites and epitopes since its emergence in 1968.

Results: It was found that both the number of HA N-glycosylation sites and the electric charge of HA increased gradually up to 2016. The charges of HA and HA1 increased respectively 1.54-fold (+7.0 /+17.8) and 1.08-fold (+8.0/+16.6) and the number of NGS in nearly doubled (7/12). As great diversities occurred in 1990s, involving Epitope A, B and D mutations, the charged amino acids in Epitopes A, B, C and D in HA1 mutated at a high frequency in global circulating strains last decade. The charged amino acid mutations in Epitopes A (T135K) has shown high mutability in strains near years, resulting in a decrease of NGT135-135. Both K158N and K160T not only involved mutations charged in epitope B, but also caused a gain of NYT158-160. Epitope B and its adjacent N-glycosylation site NYT158-160 mutated more frequently, which might be under greater immune pressure than the rest.

Conclusions: The charged amino acid mutations in A/H3N2 Influenza play a significant role in virus evolution, which might cause an important public health issue. Variability related to both the epitopes (A and B) and N-glycosylation is beneficial for understanding the evolutionary mechanisms, disease pathogenesis and vaccine research.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Charged amino acid mutations on HA epitopes in variants/vaccine strains.
Nine variants/vaccine strains were analyzed and only charged amino acids included. Both acidic amino acids [Aspartic acid (D) and Glutamic acid (E)] and basic amino acids [Lysine (K), Arginine (R) and Histidine (H)] labeled in different colors. The epitopes identified referred to Reference 7, 14 and the article (Lees WD, et al. J Virol. 2011. doi: 10.1128/JVI.00579-11).
Fig 2
Fig 2. Spatial changing of charged amino acids on HA epitopes in variants/vaccine strains.
a. Charged amino acids of five epitopes on HA included, Epitope A labeled in blue (124, 133, 135, 142 and 145), B in red (155, 156, 158, 160, 189, 190, 193 and 197), C in green (50, 53, 275, 276, 278, 279, 307 and 310), D in yellow (172, 173, 201, 207, 208, 222, 225 and 246) and E in cyan (57, 62, 63, 75, 82, 83, 92 and 261)(a.i and a-ii). b. The charged amino acids on epitopes of variants/vaccine strains were labeled, acidic ones in red, basic ones in blue and both acid and basic ones in green. c. T135K on Epitope A resulted in a decrease of NGT133-135, labeled in blue (T135K) and cyan and K160T on Epitope B did in an increase of NYT158-160, labeled in red (K160T) and cyan. Other amino acids on epitopes adjacent to NGS were labeled in green.
Fig 3
Fig 3. Charges and numbers of NGSs in HA and NA monomer.
a. HA, b. NA. Horizontal axis marked the year and both vertical axes marked the charge values (left) and the NGS number (right). The Potential NGSs of HA and NA were analyzed using NetNGlyc 1.0 Server (http://www.cbs.dtu.dk/services/Net-NGlyc/). N-glycosylated sites predicted with “++” or “+++” score would include.
Fig 4
Fig 4. Mutations of NGSs in HA and NA of A/H3N2 on variants/vaccine strains.
The mutations of NGSs on HA and NA included respectively 14 and 11 NGSs. The original NGS apearing in 1968 and preserving was labelled in green colour, then disapearing in red. The emerging NGS preserving up to date was labelled in blue colour, then disapearing in cyan.
Fig 5
Fig 5. Electric charges of antigenic epitopes in HA1.
The chronological changes of charge of five HA antigenic epitopes (A to E) were displayed separately. The dashed line(-), dot(●) and block(■) showed respectively the average, maximum and minimum charge values while the average charge levels in different epitopes were in diversities. As the less genes included in GenBank in the first two decades, data from 1968 to 1987 were divided into 6 groups, including 1968-1971(n = 20), 1972-1973(n = 19), 1974-1975(n = 18), 1976-1979(n = 24), 1980–1983 (n = 25) and 1984-1987(n = 22). The data during 1988–2016 were annually analyzed. The average charge of each epitope was unweighted by the number.

References

    1. Cai J, Wang X, Zhao B, Yao W, Wang X, Zhu Q, et al. Prevalence, genetic drift of haemagglutinin, and antiviral resistance of influenza A/H3N2 viruses circulating in Shanghai in children during 2009–2012. Journal of Medical Virology. 2014; 86:1026–1033. doi: 10.1002/jmv.23854 . - DOI - PubMed
    1. Broberg E, Snacken R, Adlhoch C, Beaute J, Galinska M, Pereyaslov D, et al. Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype. Euro Surveill. 2015; 20 . - PubMed
    1. Sugaya N, Shinjoh M, Kawakami C, Yamaguchi Y, Yoshida M, Baba H, et al. Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan. Euro Surveill. 2016; 21 doi: 10.2807/1560-7917.ES.2016.21.42.30377 . - DOI - PMC - PubMed
    1. Davlin SL, Blanton L, Kniss K, Mustaquim D, Smith S, Kramer N, et al. Influenza Activity—United States, 2015–16 Season and Composition of the 2016–17 Influenza Vaccine. MMWR Morb Mortal Wkly Rep. 2016. June 10;65(22):567–575. doi: 10.15585/mmwr.mm6522a3 . - DOI - PubMed
    1. Wu C, Wang MH, Lu X, Chong KC, He J, Yau CY, et al. Concurrent epidemics of influenza A/H3N2 and A/H1N1pdm in Southern China: A serial cross-sectional study. J Infect. 2016; 72:369–376. doi: 10.1016/j.jinf.2015.12.013 . - DOI - PubMed

MeSH terms